UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062710
Receipt number R000071801
Scientific Title Evaluation of Standard Specimen Preparation Method and Diagnostic Accuracy for Endometrial Cytology Using ThinPrep Liquid-Based Cytology
Date of disclosure of the study information 2026/08/27
Last modified on 2026/08/27 14:02:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of Endometrial Cytology Using ThinPrep Liquid-Based Cytology

Acronym

Evaluation for Endometrial Cytology Using ThinPrep

Scientific Title

Evaluation of Standard Specimen Preparation Method and Diagnostic Accuracy for Endometrial Cytology Using ThinPrep Liquid-Based Cytology

Scientific Title:Acronym

Evaluation for Endometrial Cytology Using ThinPrep Liquid-Based Cytology

Region

Japan


Condition

Condition

Endometrial Cancer

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

For patients requiring pathological evaluation of the endometrium (uterine corpus), this study aims to clarify the validity of the standard specimen preparation method and the diagnostic accuracy of ThinPrep endometrial cytology by comparing cytologic interpretation results with histological diagnosis results.

Basic objectives2

Others

Basic objectives -Others

Endometrial cytology is a primary initial test for detecting endometrial cancer. While the lesion detection rate of endometrial cytology in Japan is considered comparable or superior to that of histological diagnosis, the diagnostic accuracy for cases classified as "suspicious" (equivocal) is reported to be around 50%, indicating that diagnostic performance is not necessarily optimal. ThinPrep is the most widely adopted method globally and accounts for approximately 50% of the liquid-based cytology (LBC) market in Japan. Therefore, this study - which examines the cytological appearance of samples prepared using the standard ThinPrep method, establishes diagnostic criteria, and evaluates diagnostic accuracy - is expected to contribute to the further adoption and improved accuracy of endometrial cytology.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) Proportion of adequate samples in endometrial cytology using the standard ThinPrep slide preparation method
2) Comparison of ThinPrep interpretation results with histological diagnosis results (sensitivity, specificity, positive predictive value, and negative predictive value of ThinPrep interpretations relative to histological diagnoses; Cytology positive: ATEC-AE, atypical endometrial hyperplasia, or malignant tumor based on TYS classification; Histology positive: atypical endometrial hyperplasia or malignant tumor)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Women aged 18 years or older requiring pathological evaluation of the endometrium (uterine corpus) who underwent both cytology and histology - specifically, those who underwent histology either concurrently with cytology or within three months following the cytology procedure.

Key exclusion criteria

Patients who do not provide consent; patients deemed unsuitable for participation by their attending physician.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Matsumoto

Organization

Ehime University Hospital

Division name

Obstetrics and Gynecology

Zip code

790-0295

Address

454 Shizugawa, Toon City, Ehime

TEL

089-960-5379

Email

matsugen@m.ehime-u.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Matsumoto

Organization

Ehime University Hospital

Division name

Obstetrics and Gynecology

Zip code

790-0295

Address

454 Shizugawa, Toon City, Ehime

TEL

089-960-5379

Homepage URL


Email

matsugen@m.ehime-u.ac.jp


Sponsor or person

Institute

Ehime University

Institute

Department

Personal name



Funding Source

Organization

Suzuka Steering Committee

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board for Clinical Research, Ehime University Hospital

Address

454 Shizugawa, Toon City, Ehime

Tel

089-960-5172

Email

rinri@m.ehime-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 08 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 06 Month 04 Day

Date of IRB

2026 Year 06 Month 03 Day

Anticipated trial start date

2026 Year 06 Month 08 Day

Last follow-up date

2028 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2026 Year 08 Month 27 Day

Last modified on

2026 Year 08 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071801